Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Organon |
---|---|
Information provided by: | Organon |
ClinicalTrials.gov Identifier: | NCT00620464 |
The primary purpose of this study is to demonstrate the bioequivalence of IMPLANON and Radiopaque IMPLANON. As a secondary objective, the x-ray visibility of Radiopaque IMPLANON will be assessed.
Condition | Intervention | Phase |
---|---|---|
Contraception |
Drug: Radiopaque Implanon Drug: Implanon (etonogestrel implant) |
Phase III |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Bio-equivalence Study |
Official Title: | A Randomized, Double-Blind, Parallel Group, Bioequivalence Study of IMPLANON and Radiopaque IMPLANON |
Enrollment: | 108 |
Study Start Date: | May 2005 |
Estimated Study Completion Date: | April 2009 |
Estimated Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Arm 1: Active Comparator
Radiopaque Implanon
|
Drug: Radiopaque Implanon
Radiopaque rod for 3 years
|
Arm 2: Active Comparator
Implanon (etonogestrel implant)
|
Drug: Implanon (etonogestrel implant)
Implanon (etonogestrel implant) for 3 years
|
Ages Eligible for Study: | 18 Years to 40 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contraindications:
Responsible Party: | NV Organon, part of Schering-Plough Corporation ( Study Director ) |
Study ID Numbers: | 34528, P05720 |
Study First Received: | February 11, 2008 |
Last Updated: | January 12, 2009 |
ClinicalTrials.gov Identifier: | NCT00620464 |
Health Authority: | France: Afssaps - French Health Products Safety Agency; Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Desogestrel 3-keto-desogestrel |
Contraceptive Agents Therapeutic Uses Physiological Effects of Drugs |
Contraceptive Agents, Female Reproductive Control Agents Pharmacologic Actions |